The Supply of Covaxin to 16 States: Bharat Biotech. Bharat Biotech distributed Covaxin, a Covid-19 vaccine, to nine states through the Indian government. And to sixteen states through the various state governments.
Suchitra Ella, the company’s co-founder, and joint managing director tweeted on Wednesday that the vaccinations were distributed by the government of India. To Andhra Pradesh, Assam, Delhi, Gujarat, Karnataka, Madhya Pradesh, Maharashtra, Tamil Nadu, and Telangana between June 8 and 14.
Additionally, the Hyderabad-based vaccine manufacturer supplied vaccines to 16 states over the same time period. Assam, Bihar, Chhattisgarh, Delhi, Haryana, Jharkhand, Karnataka. Madhya Pradesh, Odisha, Punjab, Rajasthan, Tamil Nadu, Telangana, Tripura, Uttarakhand, and West Bengal are the participating states.
Additionally, she tweeted that from June 8 to 14, vaccination doses were sent to private hospitals in 27 locations throughout the nation.
Delhi, Mumbai, Chennai, Kolkata, Bangalore, and Hyderabad are among them. This group included seven cities in Telangana and Andhra Pradesh.
She has not, however, given specifics such as the number of dosages distributed in each of the three groups.
The firm defended its differential pricing strategy for the federal and state governments, as well as the private sector, on Monday.
It said that the government of India’s supply price of Covaxin, Rs 150 per dosage, is uncompetitive and obviously unsustainable in the long term. As a result, it added in a statement. A higher price in private markets is in need to cover some of the expenses.
The firm said that the higher price for Covaxin in the private sector is due to basic business factors, including limited procurement quantities, high distribution expenses, and poor retail margins.
Covaxin is the third most costly vaccine on the global market, costing Rs 1,200 per dose in premium clinics.
Bharat Biotech first priced Covaxin at Rs 600 per dosage for state governments but subsequently reduced it to Rs 400.